Cargando…
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial
BACKGROUND: Neuroendocrine tumors (NETs) are the second most common gastrointestinal malignancy after colon cancer. Up to 90% of patients with NETs develop liver metastases, which are a major determinant of symptoms and survival. Current guidelines recommend embolotherapy for progressive or symptoma...
Autores principales: | Chen, James X., Wileyto, E. Paul, Soulen, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050671/ https://www.ncbi.nlm.nih.gov/pubmed/30016989 http://dx.doi.org/10.1186/s13063-018-2782-5 |
Ejemplares similares
-
Neurostimulation for cognitive rehabilitation in stroke (NeuroCog): study protocol for a randomized controlled trial
por: Andrade, Suellen Marinho, et al.
Publicado: (2015) -
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
por: Olofsson, Roger, et al.
Publicado: (2014) -
Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial – The NeuroMorfeo trial
por: Citerio, Giuseppe, et al.
Publicado: (2009) -
Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet study): study protocol for a randomized controlled trial
por: Fretland, Åsmund Avdem, et al.
Publicado: (2015) -
Protocol for a confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastases
por: Zenda, Sadamoto, et al.
Publicado: (2023)